OHSU
Categories | Inventors

Rabbit polyclonal antibodies directed against HCMV proteins gH, gL, UL128, UL130 and UL131

 

OHSU # 1260

Summary:

Technology Overview: Rabbit polyclonal antibodies against human cytomegalovirus (CMV) proteins gH, gL, UL128, UL130 and UL131 have been developed. These are useful for research involving CMV. Please refer to the following publication for more information on these antibodies.

Publications: Ryckman B.J., Rainish B.L., Chase M.C., Borton J.A., Nelson, J.A., Jarvis M.A., Johnson D.C. Characterization of the Human Cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virology (2008) 82(1):60-70.

Licensing Opportunity: The polyclonal antisera are available for non-exclusive licensing.

Inventors:

Related Technologies:

  • OHSU # 1260-A — Rabbit polyclonal antibody directed against human cytomegalovirus protein gH
  • OHSU # 1260-B — Rabbit polyclonal antibody directed against human cytomegalovirus protein gL
  • OHSU # 1260-C — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL128
  • OHSU # 1260-D — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL130
  • OHSU # 1260-E — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL131

Categories:

For more information, contact:

Trina Voss
Technology Development Manager
503-494-9839